2min chapter

Diabetes Core Update cover image

Diabetes Core Update – May 2023

Diabetes Core Update

CHAPTER

GLP1 Receptor Agonist and SGLT2 Inhibitors for Type 2 Diabetes

The study included a little over 1,300 participants and they estimated from that that 22.5 million United States adults who were diagnosed with type 2 diabetes would be 82%. Of those meeting the criteria, 3.7 used GLP1s, 5.3% used SGLT2s and a total for both combined is that 9% of the eligible individuals were actually being prescribed those medications.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode